Preoperative detection of prostate cancer: A comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging

Journal of Magnetic Resonance Imaging

Volumn 31, Issue 5, 2010, Pages 1151-1156

  Watanabe, Haruo ^a   Kanematsu, Masayuki ^a   Kondo, Hiroshi ^a,b   Kako, Nobuo ^b   Yamamoto, Naoki ^b   Yamada, Toru ^b   Goshima, Satoshi ^a   Hoshi, Hiroaki ^a   Bae, Kyongtae T ^c  

^a GIFU UNIVERSITY HOSPITAL   (Japan)

^b Kizawa Memorial Hospital   (Japan)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Choline; Fluorodeoxyglucose; MRI; Positron emission tomography; Prostatic neoplasms

Indexed keywords

CHOLINE C 11; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY;

ADENOCARCINOMA; AGED; CARBON RADIOISOTOPES; CHOLINE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROGNOSIS; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 77951523556     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22157     Document Type: Article

References (35)

1. Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6.630 men. J Urol 1994;15:1283-1290.
2. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 2004 27;350:2239-2246.
3. Sedelaar JP, Vijverberg PL, De Reijke TM, et al. Transrectal ultrasound in the diagnosis of prostate cancer: state of the art and perspectives. Eur Urol 2001;40:275-284. (Pubitemid 34701897)
4. Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology 2007;243:28-53. (Pubitemid 46579693)
5. Fütterer JJ, Engelbrecht MR, Huisman HJ, et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 2005;237:541-549.
6. Mullerad M, Hricak H, Kuroiwa K, et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 2005;174:2158-2163. (Pubitemid 41611764)
7. Farsad M, Schiavina R, Castellucci P, et al. Detection and localization of prostate cancer: correlation of (11) C-choline PET/CT with histopathologic step-section analysis. J Nucl Med 2005;46:1642-1649.
8. Yamaguchi T, Lee J, Uemura H, et al. Prostate cancer: a comparative study of (11) C choline PET and MR imaging combined with proton MR spectroscopy. Eur J Nucl Med Mol Imaging 2005;32:742-748.
9. Picchio M, Messa C, Landoni C, et al. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography. J Urol 2003;169:1337-1340. (Pubitemid 36323779)
10. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 1998;39:990-995. (Pubitemid 28270113)
11. Sutinen E, Nurmi M, Roivainen A, et al. Kinetics of [11C] choline uptake in prostate cancer: a PET study. Eur J Nucl Med Mol Imaging 2003;31:317-324.
12. De Jong IJ, Pruim J, Elsinga PH, et al. Visualization of prostate cancer with 11C-choline positron emission tomography. Eur Urol 2002;42:18-23. (Pubitemid 35345101)
13. Engelbrecht MR, Huisman HJ, Laheij RJ, et al. Discrimination of prostate cancer from peripheral zone and central gland tissue using dynamic contrast-enhanced MR imaging. Radiology 2003;229:248-254.
14. Reske SN, Blumstein NM, Neumaier B, et al. Imaging prostate cancer with 11C-Choline PET/CT. J Nucl Med 2006;47:1249-1254. (Pubitemid 47544875)
15. Testa C, Schiavina R, Lodi R, et al. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-Choline PET/CT. Radiology 2007;244:797-806.
16. Scher B, Seitz M, Albinger W, et al. Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer. Eur J Nucl Med Mol Imaging 2007;34:45-53. (Pubitemid 44885553)
17. Gittes RF. Carcinoma of the prostate. N Engl J Med 1991;324:236-245.
18. Greene FL, Page DL, Fleming ID, et al, editors. AJCC cancer staging handbook. 6th ed. New York, NY: Springer-Verlag; 2002. p 340-341.
19. Pontes JE, Montie J, Klein E, Huben R. Salvage surgery for radiation failure in prostate cancer. Cancer 1993;71:976-980. (Pubitemid 23049619)
20. Rogers E, Ohori M, Kassabian VS, Wheeler TM, Scardino PT. Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol 1995;153:104-110. (Pubitemid 24379808)
21. Jager GJ, Ruijter ET, van de Kaa CA, et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 1997;203:645-652.
22. Kim CK, Park BK, Kim B. Localization of prostate cancer using 3T MRI: comparison of T2-weighted and dynamic contrast-enhanced imaging. J Comput Assist Tomogr 2006;30:7-11. (Pubitemid 43052291)
23. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0,7 cm3) spatial resolution. Radiology 1996;198:795-805.
24. Wefer AE, Hricak H, Vigneron DB, et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 2000;164:400-404. (Pubitemid 30481935)
25. Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging: clinicopathologic study. Radiology 1999;213:473-480. (Pubitemid 29510595)
26. Schiepers C, Hoh CK. Positron emission tomography as a diagnostic tool in oncology. Eur Radiol 1998;8:1481-1494. (Pubitemid 128662821)
27. Effert PJ, Bares R, Handt S, Wolff JM, Bull U, Jakse G. Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose. J Urol 1996;155:994-998. (Pubitemid 126425655)
28. Liu IJ, Zafar MB, Lai YH, Segall GM, Terris MK. Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer. Urology 2001;57:108-111. (Pubitemid 32065829)
29. Morris MJ, Akhurst T, Osman I, et al. Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer. Urology 2002;59:913-918. (Pubitemid 34522186)
30. Farsad M, Schiavina R, Castellucci P, et al. Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis. J Nucl Med 2005;46:1642-1649.
31. Sakr WA, Grignon DJ. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship to pathologic parameters, volume and spatial distribution of carcinoma of the prostate. Anal Quant Cytol Histol 1998;20:417-423.
32. Bostwick DG, Qian J. High-grade prostatic intraepithelial neoplasia. Mod Pathol 2004;17:360-379.
33. Mazaheri Y, Shukla-Dave A, Hricak H, et al. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging - correlation with pathologic findings. Radiology 2008;246:480-488.
34. Sato C, Naganawa S, Nakamura T, et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 2005;21:258-262. (Pubitemid 40280120)
35. Shimofusa R, Fujimoto H, Akamata H, et al. Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr 2005;29:149-153.